BBIO ▲ +1.2% - BridgeBio Pharma, Inc. $BBIO - BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels 05-OCT-2026 07:30 AM ET